News & Press Releases

Filter
401 found

MMV’s CEO delivers strong message at Oslo malaria conference

13 Apr 2011
General

Anacor Pharmaceuticals and MMV sign agreement to pursue promising compound for malaria

18 Mar 2011
Partner, R&D

WHO: Low quality drugs continue to afflict Africa

25 Feb 2011
General

G-FINDER 2010: Good news with a twist in the tail for PDPs

18 Feb 2011
Donors, General

Jomaa Pharma and MMV to co-develop novel malaria treatment based on fosmidomycin

15 Feb 2011
Partner, R&D

Single-dose cure for malaria edges closer to the clinic

08 Feb 2011
Partner, R&D

MMV signs MoU with ALMA at the African Union Summit

03 Feb 2011
Access & product management, Partner

Ground-breaking trial underway to protect pregnant women from malaria

28 Jan 2011
R&D

WHO report calls for urgent action to protect malaria therapies

12 Jan 2011
General

Global plan for artemisinin resistance containment (GPARC)

11 Jan 2011
General

MMV's new CEO comes on board

05 Jan 2011
General

Letter from the CEO

22 Dec 2010
General

World Malaria Report shows scale-up of control activities is paying-off

14 Dec 2010
General

International status granted to three not-for-profit organizations in Switzerland

09 Dec 2010
General

WHO report calls for greater vigilance to allow early detection of artemisinin resistance

18 Nov 2010
General

Conclusive win of artesunate over quinine

08 Nov 2010
R&D

MMV-supported artesunate for injection receives WHO prequalification

08 Nov 2010
R&D

MMV announces new Chairman of the Board effective 2011

21 Oct 2010
General

Germany to give €20M to neglected disease research

20 Oct 2010
Donors

MMV appoints new CEO

12 Oct 2010
General

MMV ESAC member in Times Top 100 Scientists

11 Oct 2010
General

Optimizing development of combination therapies: the regulatory perspective

08 Oct 2010
R&D

Selecting the right partner drug: experts debate the issues

13 Sep 2010
R&D

MMV, Novartis and partners discover novel antimalarial drug candidate

03 Sep 2010
R&D

MMV becomes first PDP to make its IP freely available for neglected diseases research

16 Aug 2010
R&D

MMV to screen Ferrer compound library

15 Jul 2010
R&D

Malawi – determined to control malaria

14 Jul 2010
Access & product management

AstraZeneca and MMV join efforts in the fight against malaria

28 Jun 2010
R&D

Data from MMV-supported research now in the public domain

20 May 2010
Open source, R&D

Experts sought for Global Fund Technical Review Panel

14 May 2010
General

Over 5 million compounds screened

03 May 2010
R&D

MMV and Anacor join hands in hunt for new antimalarial compounds

26 Apr 2010
Partner, R&D

Ambrose Talisuna: Advocating for access

23 Apr 2010
Access & product management

MMV supports trials of a new preventive treatment option for pregnant women

23 Apr 2010
Partner, R&D

The Countdown to Counting Out Malaria in 2010

20 Apr 2010
General

Pyramax® submitted to EMA for regulatory approval

08 Apr 2010
Partner, R&D

Roll Back Malaria (RBM) Partnership Call for Nomination for Research and Academia constituency

08 Apr 2010
Partner

MMV welcomes Dennis Schmatz as CEO

07 Apr 2010
General

MMV co-hosted meeting for donors in Barcelona - an unqualified success

24 Mar 2010
Donors, General

MMV’s Project of the Year for 2009 goes to Spiroindolones

15 Mar 2010
R&D

Memorial donation in memory of Prof. Dr. Michaela von Freyhold

02 Feb 2010
Donors, General

MMV in Trends in Parasitology

01 Feb 2010
R&D

MMV-GSK compound library screening to be made public

20 Jan 2010
R&D

Join the CRIMALDDI online discussion

20 Jan 2010
R&D

World Malaria Report 2009

15 Dec 2009
General

MMV 10th Anniversary Seminars: presentations and video clips

04 Dec 2009
General

Outstanding review of MMV by Philanthropy Advisory Service

01 Dec 2009
Donors, Partner

MMV’s President and CEO to step down in 2010

23 Nov 2009
General

MMV and sanofi-aventis launch ambitious antimalarial monitoring programme

19 Nov 2009
R&D

MMV at ASTMH 2009

11 Nov 2009
Access & product management, General

MMV in Nature Reviews Drug Discovery

06 Nov 2009
R&D

MMV at MIM 2009

26 Oct 2009
General

MMV at a Glance - a brochure about MMV

22 Oct 2009
General

MMV receives $115 million from Gates Foundation

19 Oct 2009
Donors

MMV supports the need for subsidized antimalarials

12 Oct 2009
Access & product management

New EU-funded project to coordinate antimalarial drug research

24 Aug 2009
R&D

Price of Coartem® reduced for the third time in 8 years

13 Aug 2009
Access & product management

MMV and Treague take development of (+) Mefloquine into Phase I

10 Jul 2009
R&D

Dihydroartemisinin-piperaquine submitted to EMEA for regulatory approval

06 Jul 2009
R&D

Malaria and the G8

03 Jul 2009
General

Pages